Ronald K. Ross focuses on Internal medicine, Risk factor, Breast cancer, Cancer and Estrogen. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Exon. His studies deal with areas such as Case-control study, Immunology, Prospective cohort study, Prostate cancer and Physiology as well as Risk factor.
His study in Breast cancer is interdisciplinary in nature, drawing from both Odds ratio, Menstrual cycle and Oncology. He combines subjects such as Gynecology and Incidence with his study of Cancer. In his research, Progesterone secretion is intimately related to Mammary gland, which falls under the overarching field of Estrogen.
Ronald K. Ross mainly investigates Internal medicine, Breast cancer, Cancer, Risk factor and Epidemiology. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Oncology. His Breast cancer research includes themes of Gynecology, Case-control study and Obstetrics.
His Cancer study incorporates themes from Relative risk and Prospective cohort study. In his study, Confidence interval, Family history and Gastroenterology is strongly linked to Odds ratio, which falls under the umbrella field of Risk factor. The Epidemiology study combines topics in areas such as Surgery, Incidence, Public health and Environmental health.
Ronald K. Ross spends much of his time researching Internal medicine, Risk factor, Breast cancer, Oncology and Cancer. His biological study spans a wide range of topics, including Endocrinology and Surgery. His work carried out in the field of Risk factor brings together such families of science as Epidemiology, Case-control study, Genotype, Endometrial cancer and Physiology.
His Breast cancer research integrates issues from Gynecology, Estrogen and Obstetrics. The concepts of his Oncology study are interwoven with issues in Cancer registry, Obesity and Disease. His studies in Cancer integrate themes in fields like Hysterectomy, Prospective cohort study, Pediatrics and Gerontology.
Ronald K. Ross mainly focuses on Risk factor, Internal medicine, Breast cancer, Case-control study and Endocrinology. His research in Risk factor intersects with topics in Bladder cancer, Prospective cohort study, Urinary bladder and Physiology. His Internal medicine research focuses on Cancer in particular.
His Breast cancer research incorporates themes from Endometrial cancer, Estrogen, Gerontology and Obstetrics. Ronald K. Ross has researched Case-control study in several fields, including Odds ratio and Surgery. His Endocrinology research integrates issues from Prostate cancer and Androgen receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin
Ronald K. Ross;Annlia Paganini-hill;Peggy C. Wan;Malcolm C. Pike.
Journal of the National Cancer Institute (2000)
Endogenous Hormones and Breast Cancer Risk
Leslie Bernstein;Ronald K. Ross.
Epidemiologic Reviews (1993)
Decreased Mortality in Users of Estrogen Replacement Therapy
B.E. Henderson;A. Paganini-Hill;R.K. Ross.
JAMA Internal Medicine (1991)
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.
Geng Sun Qian;Ronald K. Ross;Mimi C. Yu;Jian Min Yuan.
Cancer Epidemiology, Biomarkers & Prevention (1994)
Physical Exercise and Reduced Risk of Breast Cancer in Young Women
Leslie Bernstein;Brain E. Henderson;Rosemarie Hanisch;Jane Sullivan-Halley.
Journal of the National Cancer Institute (1994)
Menopausal estrogen therapy and hip fractures.
Annlia Paganini-Hill;Ronald K. Ross;Vibeke R. Gerkins;Brian E. Henderson.
Annals of Internal Medicine (1981)
Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China.
Stephanie J London;Jian-Min Yuan;Fung-Lung Chung;Yu-Tang Gao.
The Lancet (2000)
Do regular ovulatory cycles increase breast cancer risk
Brian E. Henderson;Ronald K. Ross;Howard L. Judd;Mark D. Krailo.
Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA
Nick M. Makridakis;Ronald K. Ross;Malcolm C. Pike;Laura E. Crocitto.
The Lancet (1999)
Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.
Ronald K. Ross;Malcolm C. Pike;Gerhard A. Coetzee;Juergen K. V. Reichardt.
Cancer Research (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: